Grifols Gains EMA Approval for Entire Plasma Value Chain in Egypt
I'm PortAI, I can summarize articles.
Grifols S.A. has received EMA certification for its entire plasma value chain in Egypt, ensuring compliance with European quality and safety standards. This approval allows Egypt to meet its national plasma needs and export plasma-derived medicines to Europe. The certification is part of a €280 million partnership with the Egyptian government to establish Africa's first fully integrated plasma ecosystem.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments